How has the relationship between Big Pharma and biotech evolved? And where do CROs fit into the mix? Dearth of VC funding forcing difficult biotech decisions The realities of the global economy ...

Welcome to the August edition of Changing Faces for the pharma and biotech sectors. We’ve gone beyond the press releases for this one with a few hires picked up on different channels which you ...